Featured Content

Common Causes of Drug-Induced Seizures 1/20/2010

Among others, bupropion, tramadol, and venlafaxine are reported as potential risks in this patient population.


Related Content

Disorders Associated With Celiac Disease

With celiac disease, the risk of developing other autoimmune and nonautoimmune disorders increases.

Pharmaceutical Care of Celiac Disease

Celiac disease, also known as gluten-sensitive enteropathy or sprue, is a chronic autoimmune disorder caused by a genetic intolerance to gluten.

Labeling Guidelines for Antipsychotics During Pregnancy

The labeling for all antipsychotics will be updated to include an enhanced pregnancy section. 

Benign Prostatic Hyperplasia and the Medication Management of Associated Lower Urinary Tract Symptoms

Serious complications can occur if this common benign tumor goes untreated.



Calcium Kidney Stones: Pathogenesis, Evaluation, and Treatment Options

Pharmacists should counsel these patients about lifestyle, dietary factors, and medication effects. 

SENIOR CARE

Caring for the Aging: Key Health Care Legislation 6/18/2009

Various resources can assist pharmacists in honing the skills necessary to serve American seniors with quality care.


View Full Article

Assisting Seniors With Insomnia: A Comprehensive Approach 6/18/2009

Insomnia is a common but often underdiagnosed complaint in the elderly population.

Assessing Pain in the Cognitively Impaired 5/19/2009

Pharmacists may help caregivers provide appropriate care by educating them on the use of pain scales and observational clues.

Venous Thrombosis: Pathogenesis and Potential for Embolism 2/20/2009

With advancing age greater than 60 years a known risk, deep vein thrombosis is the primary cause of pulmonary embolism.

Contrast-Induced Nephropathy 12/15/2008

Visualizing organs of the gastrointestinal (GI) tract, such as the liver and gallbladder, and detecting cysts, abscesses, tumors, and obstructions can be achieved through radiographic imaging.

Antipsychotics in Seniors 11/18/2008

The FDA has determined new data provide evidence concluding the conventional antipsychotic agents share the increased risk of death in elderly patients with dementia-related psychosis that has been documented with the atypical antipsychotics.

Advertisement